Correction to: Effectiveness of Switching from Reference Product Infliximab to Infliximab-Dyyb in Patients with Inflammatory Bowel Disease in an Integrated Healthcare System in the United States: A Retrospective, Propensity Score-Matched, Non-Inferiority Cohort Study
- Resource Type
- Erratum
- Source
- BioDrugs. 34(3):405-405
- Subject
- Language
- English
- ISSN
- 1173-8804
1179-190X